1. Home
  2. CLRB vs TRUG Comparison

CLRB vs TRUG Comparison

Compare CLRB & TRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLRB
  • TRUG
  • Stock Information
  • Founded
  • CLRB 2002
  • TRUG 1983
  • Country
  • CLRB United States
  • TRUG United States
  • Employees
  • CLRB N/A
  • TRUG N/A
  • Industry
  • CLRB Biotechnology: Pharmaceutical Preparations
  • TRUG
  • Sector
  • CLRB Health Care
  • TRUG
  • Exchange
  • CLRB Nasdaq
  • TRUG NYSE
  • Market Cap
  • CLRB 15.3M
  • TRUG 16.2M
  • IPO Year
  • CLRB N/A
  • TRUG N/A
  • Fundamental
  • Price
  • CLRB $0.31
  • TRUG $0.47
  • Analyst Decision
  • CLRB Buy
  • TRUG Strong Buy
  • Analyst Count
  • CLRB 2
  • TRUG 1
  • Target Price
  • CLRB $28.00
  • TRUG $2.00
  • AVG Volume (30 Days)
  • CLRB 1.4M
  • TRUG 5.4M
  • Earning Date
  • CLRB 03-26-2025
  • TRUG 03-04-2025
  • Dividend Yield
  • CLRB N/A
  • TRUG N/A
  • EPS Growth
  • CLRB N/A
  • TRUG N/A
  • EPS
  • CLRB N/A
  • TRUG N/A
  • Revenue
  • CLRB N/A
  • TRUG $21,917,131.00
  • Revenue This Year
  • CLRB N/A
  • TRUG $11.00
  • Revenue Next Year
  • CLRB N/A
  • TRUG $20.54
  • P/E Ratio
  • CLRB N/A
  • TRUG N/A
  • Revenue Growth
  • CLRB N/A
  • TRUG 7.68
  • 52 Week Low
  • CLRB $0.22
  • TRUG $0.35
  • 52 Week High
  • CLRB $4.45
  • TRUG $2.27
  • Technical
  • Relative Strength Index (RSI)
  • CLRB 46.10
  • TRUG 48.97
  • Support Level
  • CLRB $0.26
  • TRUG $0.36
  • Resistance Level
  • CLRB $0.35
  • TRUG $0.67
  • Average True Range (ATR)
  • CLRB 0.03
  • TRUG 0.05
  • MACD
  • CLRB 0.02
  • TRUG 0.01
  • Stochastic Oscillator
  • CLRB 61.40
  • TRUG 31.69

About CLRB Cellectar Biosciences Inc.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. Its PDC therapeutic, iopofosine is a small-molecule PDC designed to provide targeted delivery of iodine-131 directly to cancer cells, while limiting exposure to healthy cells.

About TRUG TRUGOLF HOLDINGS INC

TruGolf Holdings Inc is a indoor golf gaming solutions company. It has built video games ("Links"), innovative hardware solutions, and an all-new e-sports platform to connect golfers around the world with E6 CONNECT.

Share on Social Networks: